Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
Inv. presentation
|
|
Celldex Therapeutics, Inc. (CLDX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/10/2023 |
SC 13G/A
| WELLINGTON MANAGEMENT GROUP LLP reports a 10.1% stake in Celldex Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 0% stake in Celldex Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/01/2023 |
SC 13G/A
| STATE STREET CORP reports a 4.9% stake in EXIT FILING CELLDEX THERAPEUTICS INC |
| 02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 4.6% stake in Celldex therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| RTW INVESTMENTS, LP reports a 8.4% stake in Celldex Therapeutics, Inc. |
| 02/10/2022 |
SC 13G/A
| ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 1.4% stake in Celldex Therapeutics, Inc. |
| 02/09/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/18/2022 |
SC 13G/A
| Cowen Financial Products LLC reports a 0% stake in Celldex Therapeutics Inc. |
| 01/14/2022 |
SC 13G/A
| Cowen Financial Products LLC reports a 5.1% stake in Celldex Therapeutics Inc. |
| 02/12/2021 |
SC 13G/A
| Ikarian Capital, LLC reports a 3.5% stake in Celldex Therapeutics, Inc. |
| 02/12/2021 |
SC 13G/A
| RTW INVESTMENTS, LP reports a 8.7% stake in Celldex Therapeutics, Inc. |
| 02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| AMERIPRISE FINANCIAL INC reports a 0% stake in Celldex Therapeutics Inc |
| 02/11/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 07/10/2018 |
SC 13G/A
| BlackRock Inc. reports a 2.5% stake in CELLDEX THERAPEUTICS INC |
| 05/10/2018 |
SC 13G/A
| FMR LLC reports a 0% stake in CELLDEX THERAPEUTICS INC NEW |
| 02/13/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2018 |
SC 13G/A
| FMR LLC reports a 5.6% stake in CELLDEX THERAPEUTICS INC NEW |
| 02/06/2018 |
SC 13G/A
| FRANKLIN RESOURCES INC reports a 0% stake in CELLDEX THERAPEUTICS, INC. |
| 01/29/2018 |
SC 13G/A
| BlackRock Inc. reports a 7.3% stake in CELLDEX THERAPEUTICS INC |
| 12/11/2017 |
SC 13G/A
| FMR LLC reports a 5.7% stake in CELLDEX THERAPEUTICS INC NEW |
| 05/10/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/10/2017 |
SC 13G/A
| Celldex Therapeutics, Inc. reports a 6.5% stake in Celldex Therapeutics Inc |
| 02/10/2017 |
SC 13G/A
| Celldex Therapeutics, Inc. reports a 3.6% stake in EXIT FILING CELLDEX THERAPEUTICS, INC. |
| 02/09/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 01/31/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 01/23/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/04/2016 |
SC 13G/A
| Celldex Therapeutics, Inc. reports a 9.9% stake in CELLDEX THERAPEUTICS, INC. |
| 02/13/2012 |
SC 13G/A
| Celldex Therapeutics, Inc. reports a 6.3% stake in CELLDEX THERAPEUTICS INC |
|
|